Form4insider filings, from the source

Company · CIK 0001790340 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Immuneering Corp · IMRX

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $36k · 2sales $0 · 0net $36k
$10k$10k$100k$100k$1M$1MbuyssalesJun 14Jun 15Jun 17Jun 19Jun 20Jun 22Jun 24

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 23, 2026 PForm 4 →Jun 24, 4:11 pm EDTBenjamin J. ZeskindPRESIDENT AND CEO, Director2,400$4.56$10,9482,315,252+0.10%
Jun 15, 2026 PForm 4 →Jun 16, 4:15 pm EDTBrett Matthew HallCHIEF SCIENTIFIC OFFICER6,035$4.15$25,045382,531+1.60%

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jul 16, 2026 AForm 4 →Jul 17, 4:29 pm EDTAndrew GengosChief Financial Officer650,000——650,000—
Jun 11, 2026 AForm 4 →Jun 11, 5:37 pm EDTThomas J. SchallDirector33,350——33,350—
Jun 11, 2026 AForm 4 →Jun 11, 5:33 pm EDTDiana HausmanDirector33,350——33,350—
Jun 11, 2026 AForm 4 →Jun 11, 5:29 pm EDTRobert J CarpenterDirector33,350——33,350—
Jun 11, 2026 AForm 4 →Jun 11, 5:26 pm EDTLaurie KeatingDirector33,350——33,350—
Jun 11, 2026 AForm 4 →Jun 11, 5:23 pm EDTPeter FeinbergDirector33,350——33,350—